Axicabtagene Ciloleucel in Large B-Cell Lymphoma

N Engl J Med. 2023 Sep 21;389(12):1152-1153. doi: 10.1056/NEJMc2309399.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antigens, CD19* / therapeutic use
  • Humans
  • Immunotherapy, Adoptive
  • Lymphoma, B-Cell*

Substances

  • axicabtagene ciloleucel
  • Antigens, CD19